Meta Platforms
META
Oracle
ORCL
Strategy
MSTR
4
Toll Brothers
TOL
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 21.480
- +1.500+7.51%
Close May 2 16:00 ET
- 21.000
- -0.480-2.23%
Post 20:01 ET
1.43BMarket Cap-7.70P/E (TTM)
21.640High19.900Low1.99MVolume20.250Open19.980Pre Close42.15MTurnover3.02%Turnover RatioLossP/E (Static)66.61MShares53.69052wk High9.21P/B1.42BFloat Cap15.75252wk Low--Dividend TTM65.99MShs Float302.500Historical High--Div YieldTTM8.71%Amplitude2.140Historical Low21.148Avg Price1Lot Size
Tandem Diabetes Care Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -128.59%-18.28M | 176.16%24.23M | 248.52%10.72M | 48,589.09%26.78M | 16.57%-5.28M | 56.37%-8M | -163.04%-31.81M | -223.99%-7.22M | -99.77%55K | -191.62%-6.32M |
| Net income from continuing operations | -205.64%-130.56M | 56.86%-96.03M | 102.52%755K | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M |
| Operating gains losses | 179.34%3.54M | --3.32M | --2.05M | --0 | --0 | --1.27M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 6.63%4.31M | 5.68%16.61M | 5.31%4.25M | 4.67%4.21M | -3.68%4.11M | 19.05%4.04M | 9.67%15.72M | 10.71%4.03M | 14.68%4.02M | 20.04%4.27M |
| Other non cash items | 10,978.21%77.77M | -96.80%3.06M | -100.82%-135K | 98.47%-223K | -80.90%2.72M | -99.12%702K | 130.34%95.57M | 70.10%16.54M | -147.41%-14.55M | 7,197.95%14.23M |
| Change In working capital | -218.56%-5.81M | 33.38%-11.78M | -180.43%-23.32M | 153.05%15.13M | 44.35%-8.49M | 5,671.59%4.9M | -280.40%-17.69M | 53.79%-8.32M | -56.66%5.98M | -231.86%-15.26M |
| -Change in receivables | -211.04%-10.84M | -586.21%-20.8M | -115.96%-12.08M | -214.43%-11.57M | 25.71%-6.9M | -57.26%9.77M | 154.62%4.28M | -84.41%-5.6M | 62.12%-3.68M | 14.02%-9.29M |
| -Change in inventory | 204.12%9.6M | 112.62%5.81M | 104.46%595K | 221.02%10.37M | 48.13%-8.31M | 115.85%3.16M | -8.48%-46.05M | -147.48%-13.34M | 119.34%3.23M | -91.07%-16.03M |
| -Change in prepaid assets | 44.83%-2.26M | 39.11%-5.57M | -16.01%-2.14M | 132.66%1.36M | -132.90%-678K | 21.20%-4.1M | -15,656.90%-9.14M | -29.61%-1.84M | -2,493.13%-4.15M | 163.22%2.06M |
| -Change in payables and accrued expense | 297.00%6.64M | 235.71%3.16M | 82.91%4.11M | 88.22%-1.19M | -44.26%3.61M | -266.59%-3.37M | -109.68%-2.33M | 156.09%2.25M | -229.14%-10.13M | 0.23%6.48M |
| -Change in other current assets | 404.24%718K | 128.02%893K | 122.98%453K | -21.67%347K | 125.84%329K | 38.86%-236K | -164.04%-3.19M | -697.98%-1.97M | 850.85%443K | -299.06%-1.27M |
| -Change in other current liabilities | 228.79%5.64M | 54.29%18.6M | 923.76%11.33M | -51.21%2.38M | -3.54%3.16M | -38.30%1.72M | -55.98%12.05M | -45.47%1.11M | -72.84%4.89M | -62.99%3.28M |
| -Change in other working capital | -655.38%-15.3M | -151.99%-13.88M | -330.96%-25.59M | -12.64%13.43M | 163.13%303K | -383.36%-2.03M | 691.71%26.69M | 287.02%11.08M | 5.29%15.38M | 59.43%-480K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -128.59%-18.28M | 176.16%24.23M | 248.52%10.72M | 48,589.09%26.78M | 16.57%-5.28M | 56.37%-8M | -163.04%-31.81M | -223.99%-7.22M | -99.77%55K | -191.62%-6.32M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 281.69%9.19M | 72.61%-23.48M | 130.21%5.01M | 59.00%-19.9M | -162.13%-3.54M | 80.80%-5.06M | -358.50%-85.74M | -146.35%-16.58M | -242.62%-48.53M | -10.37%5.7M |
| Net PPE purchase and sale | 33.48%-2.97M | 28.25%-19.23M | 40.97%-3.07M | 2.98%-5.24M | 12.35%-6.47M | 49.51%-4.46M | 21.39%-26.8M | 7.61%-5.2M | 60.61%-5.4M | 39.12%-7.38M |
| Net intangibles purchase and sale | ---43.46M | -87.12%-46.4M | -108.24%-46.4M | --0 | --0 | --0 | -180.06%-24.8M | ---22.28M | --0 | ---515K |
| Net business purchase and sale | ---- | --0 | --0 | --0 | --0 | --0 | -170.20%-69.5M | --0 | --0 | --0 |
| Net investment purchase and sale | 9,384.64%55.62M | 19.21%42.15M | 399.89%54.48M | 66.01%-14.66M | -78.47%2.93M | -101.11%-599K | -65.28%35.36M | -73.69%10.9M | -228.41%-43.13M | -28.43%13.59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 281.69%9.19M | 72.61%-23.48M | 130.21%5.01M | 59.00%-19.9M | -162.13%-3.54M | 80.80%-5.06M | -358.50%-85.74M | -146.35%-16.58M | -242.62%-48.53M | -10.37%5.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -134.51%-4.69M | 103.43%8.37M | -12.04%2.3M | -136.47%-4.52M | -176.04%-3M | 2,611.28%13.59M | -75.63%4.11M | -57.10%2.62M | -146.90%-1.91M | -50.96%3.95M |
| Net issuance payments of debt | --0 | --60.73M | --0 | --0 | --0 | --60.73M | --0 | --0 | --0 | --0 |
| Net common stock issuance | --0 | ---30M | --0 | --0 | --0 | ---30M | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | -260.85%-6.73M | -12.04%2.3M | -145.60%-4.52M | -176.04%-3M | -179.30%-1.51M | -76.05%4.18M | -56.51%2.62M | -398.64%-1.84M | -52.55%3.95M |
| Net other financing activities | 72.65%-4.69M | -21,914.08%-15.63M | --0 | --0 | --1.51M | ---17.14M | 88.01%-71K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -134.51%-4.69M | 103.43%8.37M | -12.04%2.3M | -136.47%-4.52M | -176.04%-3M | 2,611.28%13.59M | -75.63%4.11M | -57.10%2.62M | -146.90%-1.91M | -50.96%3.95M |
| Net cash flow | ||||||||||
| Beginning cash position | 17.61%69.23M | -65.88%58.87M | -38.40%49.04M | -63.52%47.7M | -53.84%58.98M | -65.88%58.87M | 142.36%172.52M | -35.69%79.61M | 13.73%130.75M | 36.38%127.76M |
| Current changes in cash | -2,680.52%-13.78M | 108.03%9.11M | 185.11%18.03M | 104.69%2.36M | -455.61%-11.82M | 101.18%534K | -212.86%-113.44M | -144.41%-21.18M | -659.42%-50.38M | -84.41%3.32M |
| Effect of exchange rate changes | -344.44%-1.88M | 692.45%1.26M | 392.27%2.17M | -34.65%-1.02M | 260.18%535K | -195.92%-423K | -125.63%-212K | -57.45%440K | -308.06%-759K | -1,291.67%-334K |
| End cash Position | -9.16%53.57M | 17.61%69.23M | 17.61%69.23M | -38.40%49.04M | -63.52%47.7M | -53.84%58.98M | -65.88%58.87M | -65.88%58.87M | -35.69%79.61M | 13.73%130.75M |
| Free cash flow | -419.61%-64.71M | 50.36%-41.41M | -11.69%-38.76M | 502.99%21.54M | 17.40%-11.74M | 57.29%-12.45M | -1,210.40%-83.41M | -18,078.76%-34.7M | -382.36%-5.35M | -148.04%-14.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀